Health Minister Mansukh Mandaviya on Sunday said the Union government's flagship programme the Ayushman Bharat Health and Wellness Centres cannot be converted to any other scheme by state governments. Earlier, the Union Health Ministry had said the Punjab government was converting Ayushman Bharat Health and Wellness Centres (AB-HWC) into 'Mohalla Clinics', a pet project of the ruling Aam Aadmi Party, and had warned of stopping the funds for the scheme. The AB-HWC is formulated with a 60:40 contribution ratio by the Centre and the state. Mandaviya was on a visit to Patiala on Sunday during which he made a surprise visit to review the security arrangements at a NEET-PG exam centre in the city. He also interacted with the candidates' parents there. This is the first time that the Union Health minister has visited a National Board of Examinations in Medical Sciences (NBEMS) exam centre during an examination, a Health Ministry statement said. "Visited NEET-PG exam centre in Patiala,
The Union govt has given special focus on holistic development of Kerala, based on the mantra of Sabka Saath, Sabka Vikas, Sabka Vishvaas, Sabka Prayaas, said Union Health Minister Mansukh Mandaviya
Prime Minister Narendra Modi's faith in the Indian scientific community and stellar healthcare professionals across the country helped India conquer "unsurmountable challenges" during the pandemic, Union Health Minister Mansukh Mandaviya said on Saturday. He said India set an exemplary pro-vaccination Covid management model when other countries were struggling with vaccine hesitancy. Mandaviya was speaking at the release of a book -- titled 'India's Vaccine Growth Story-From Cowpox to Vaccine Maitri' -- authored by Sajjan Singh Yadav, Additional Secretary, Department of Expenditure in the Finance Ministry, at Pragati Maidan here. "The combination of Narendra Modi's faith in the Indian scientific community and the stellar healthcare professionals across country led India to conquer unsurmountable challenges to achieve a feat no country has before, catering not just to its own nation, but supplying life-saving vaccines worldwide, all in due time," the health minister said. Lauding t
Patients diagnosed with ultra-rare genetic conditions, including Lysosomal Storage Disorders, require sustainable funding support, 24 Parliamentarians from across party lines wrote to Union Health Minister Mansukh Mandaviya, seeking his intervention in the matter. Under the aegis of the Parliamentary Support Group for Rare Diseases, the MPs from both Lok Sabha and Rajya Sabha said this in a memorandum to the health ministry on Rare Disease Day, stressing the need for a sustainable fund to manage certain diseases under the National Policy for Rare Diseases, 2021. Rare Disease Day is observed every year on the last day of February. "Classified as Group 3a conditions in the National Policy for Rare Diseases, 2021, we would like to draw your attention and seek measures in putting up a mechanism to ensure continuity to all these patients, subject to a review of the progress of these patients by competent members of the Central Technical Committee on rare diseases set up by Ministry of ..
The Centre has said that daily surveillance on heat-related illnesses under National Programme on Climate Change and Human Health (NPCCHH) in all states and districts
"Within the federal democratic structure of the country, both the Centre and states are required to work together in harmony and synergy to ensure that we establish robust regulatory systems," he said
The committee will present a road map within the next one month
Union Health Minister Mansukh Mandaviya urged all the stakeholders on Sunday to steadfastly work towards building trust and confidence in the quality of Indian drugs, cosmetics and medical devices in domestic and export markets. It is of critical importance to ensure that the country's regulatory mechanisms are of impeccable standards that are sustained over time and space, Mandaviya said as he inaugurated a two-day "chintan shivir" on "Drugs: Quality Regulations and Enforcement" in Hyderabad. "How can we ensure that the confidence of the consumers of pharmaceuticals manufactured in India is upheld? I urge all the stakeholders to steadfastly work towards making the Indian drugs regulatory system among the best in the world, which could be emulated by other countries," he said. In his inaugural address, Mandaviya underlined the focus of the deliberative forum, saying, "The chintan shivir is a platform for all the stakeholders in the pharma and health sectors to deliberate on pathways
Union Health Minister Dr Mansukh Mandaviya on Friday hailed India's response to the COVID pandemic and said that the country was able to save over 3.4 million lives by undertaking the nationwide vaccination campaign at an unprecedented scale.The Health Minister lauded Prime Minister Narendra Modi's leadership during the pandemic and said that he initiated a "preemptive response" much before COVID-19 was declared a public health emergency of international concern on January 30, 2020, by the WHO.The remarks of the Minister came while delivering a keynote address virtually at Stanford 'The India Dialog' session on the Economic Impact of Vaccination & Related Matters on Friday."India was able to save more than 3.4 million lives by undertaking the nationwide vaccination campaign at an unprecedented scale. Under the PMGKAY, the government focused on ensuring that no one slept hungry and free food grains were distributed to 800 million people," he said."The report "Healing the economy:
The government is taking steps to produce "high value pharmaceuticals" in the country to reduce import dependency for such critical articles, Union Minister Mansukh Mandaviya said on Tuesday. Manufacturing of components of high-end medical devices in the country will be another big step in moving towards self reliance, the Union Minister for Chemicals and Fertilisers noted. "Working on the vision of reducing import dependency through indigenous production, the government is focussing on production of high value pharmaceuticals and high-end medical devices," he said. Mandaviya said the Department of Pharmaceuticals (DoP) has released the first tranche of incentives under the Product Linked Incentive (PLI) scheme of pharmaceuticals amounting to Rs 166 crore to four selected applicants. Under the Atmanirbharta initiative of the government, DoP launched the PLI scheme for pharmaceuticals in 2021. The financial outlay under this PLI scheme is Rs 15,000 crore over a period of six years.
The generic equivalent of Latuda tablets has been launched in the US markets
Drone manufacturer Garuda Aerospace has joined hands with healthcare provider Narayana Health towards transporting of bio-medical supplies using their 'Sanjeevani' drone, the company said on Friday. The partnership between the two aims to ensure faster delivery of medical supplies including samples for diagnosis during challenging conditions. "With the help of Garuda Aerospace's Sanjeevani drone, Narayana Health will be able to transport bio-medical supplies quickly, ensuring patients receive timely diagnosis and treatments." Garuda Aerospace said. The drones would be able to provide emergency healthcare in remote and under served areas as well, it said. "Our aim is to improve access to critical medical supplies and support the delivery to patients in need and in times of emergency," Garuda Aerospace founder-CEO Agnishwar Jayaprakash said in a statement. On their association with Garuda Aerospace, Narayana Health Chairman Dr Devi Shetty said, "by partnering with Garuda Aerospace,
The central government's free telemedicine service has clocked over 10 crore teleconsultations till now, Union Health Minister Mansukh Mandaviya on Thursday said. An initiative of the Union Ministry of Health, eSanjeevani, had among its beneficiaries 57 per cent women and around 12 per cent senior citizens, the minister said. "This platform also reflects that the platform is finding its reach in the more vulnerable sections of the population where its effect is to fetch maximum impact. "This speaks volumes about the telemedicine platform and the extent to which it has reinvented itself over time to meet the growing demands of healthcare in India," Mandaviya said. The National Telemedicine Service, "eSanjeevani," a digital health initiative of the ministry supports two types of teleconsultation services Doctor-to-Doctor (eSanjeevani) and Patient-to-Doctor (eSanjeevani OPD) teleconsultations. The eSanjeevani was rolled out in November 2019 as an important component of the Ayushman
However, random testing of 2 per cent of all travellers landing in India will continue, the health ministry has said
Union Health Minister Mansukh Mandaviya has said the government is working to equal the number of undergraduate and postgraduate medical seats within four years so that all MBBS graduates can pursue PG courses. Speaking at the 13th annual conference of the Global Association of Physicians of Indian origin (GAPIO) here on Saturday, Mandaviya also invited healthcare professionals from the Indian diaspora to invest in research and open hospital chains in the country with "assured business." More than 70 countries will sign hospital-to-hospital, country-to-country and country-to-hospital MoUs at the 'Heal In India, Heal By India' expo to be held in April-May this year, he said. "When we open a dispensary, we also need doctors. Eight years ago, India had 51,000 MBBS seats. Today, we have 1,00,226 under-graduate seats, and post-graduate seats grew from 34,000 to 64,000," the minister said. "We have set a target to make the number of MBBS UG and PG seats equal so that all our doctors get
A total of 4.34 crore hospital admissions entailing an expenditure of Rs 51,749 crore have been authorised under the government's Ayushman Bharat health insurance scheme till February 2 this year, Union Health Minister Mansukh Mandaviya informed Lok Sabha on Friday. The average per capita expenditure under the scheme is Rs 11,924, Mandaviya said in a written response to a question. The Ayushman Bharat Pradhan Mantri Jan Arogya Yojna (AB-PMJAY), launched in September 2018, provides a cover of up to Rs 5 lakh per family per year for secondary and tertiary care hospitalisation. According to Mandaviya, a total of 23.07 crore beneficiaries have been verified under the scheme for issuance of Ayushman cards as of February 2, 2023. The minister further informed that a budget of Rs 6,412 crore has been allocated to be utilised under PMJAY for 2022-23 and Rs 4,580.10 crore has been utilised till February 2. A total of 4.34 crore hospital admissions worth Rs 51,749.40 crore have been authori
The National Eligibility cum Entrance Test-Postgraduate (NEET PG 2023) will be conducted as per the schedule date on March 5, Union Health Minister Mansukh Mandaviya informed the Lok Sabha on Friday
The Centre has decided to open Integrative Medicine Centres at all government medical establishments in the country especially at AIIMS, Union Health Minister Mansukh Mandaviya said on Tuesday. Opening such centres will help in harmonising the Indian and modern systems of medicine and providing joint multidisciplinary care to patients, Mandaviya said. The health minister and Union Minister of Ayush Sarbananda Sonowal on Tuesday jointly inaugurated an Integrative Medicine Centre at the Department of Integrative Medicine of All India Institute of Ayurveda (AIIA) at Safdarjung Hospital here. Integrative medicine is aimed at harnessing the potential of India's rich heritage and medical knowledge, along with using modern advancements in allopathy, Mandaviya said. Both traditional and modern medical practices would help in providing better avenues of health and wellness, he said. "It is, thus, the need of the hour that different medical systems must not compete but complement each other
The total sale of medicines by stockists/dealers to retailers in India stood at over Rs 1.40 lakh crore during the April-December period, Rajya Sabha was informed on Tuesday. In a written reply to a query, Union Minister of Chemicals and Fertilisers Mansukh Mandaviya laid a statement on the table of the Upper House stating no separate data is, however, maintained regarding consumption of generic medicines in the country. During the April-December 2022 period, the total sales of medicines by stockists or dealers to retailers was at Rs 1,40,865.31 crore. In 2021-2022, it was at Rs 1,69,234.82 crore while the same stood at Rs 1,47,586.41 crore in 2020-2021, as per the statement. The Department of Pharmaceuticals has taken various steps for increasing the production of drugs in the country and encourage domestic manufacturing of pharmaceutical drugs, including PLI scheme for manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates (DIs)/ Active Pharmaceutical ...
Chemical and Fertilisers Minister Mansukh Mandaviya on Friday called on investors to invest in Indian plastic industry and assured a strong government support. Addressing CEOs conclave at PLASTINDIA here, the minister said, "the country boasts a strong and impartial legislative structure along with favourable manpower and technical expertise", an official statement said. "India provides a big market as the consumption power is increasing along with a rising middle class," he said and asked investors to understand India's ethos and invest in the country's growth story. More than 90 CEOs of the plastic industry from both India and abroad participated in the conference.